EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 18, Issue 1
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Volume 15 Issue 4

Regenerative Medicine: Hype and Hope or Safety and Efficacy?

Regenerative medicine, and the underlying stem cell technology on which it is based, offer considerable hope to patients suffering from trauma and acute or chronic d...
24 January 2024 Volume 15 Issue 4 chronic disease | commercialisation
Continue Reading →
Regional News

Argenx, already deep into its Vyvgart launch, charts course to become immunology ‘powerhouse’: CEO

Argenx is off to the races with the launch of its new med Vyvgart. With its first FDA-approved drug Vyvgart now rolling out, Argenx is charting a course to become an...
26 January 2022 Regional News Argenx | CEO
Continue Reading →
Regional News

Bristol Myers Squibb previews new ‘transformation’ corporate brand campaign at annual global patients’ event

Bristol Myers Squibb’s new corporate campaign celebrates transformation—of science, the pharma industry and patients’ lives. It’s the pharma’s first corporate campaig...
29 September 2021 Regional News Bristol Myers Squibb | patient
Continue Reading →
Europe

Direct-to-Patient Clinical Trials

Dates: August 09-10, 2018 Location: Philadelphia, PA Positive patient experiences lead to successful clinical trials with high adherence and high participation rates....
25 July 2018 Europe | North America clinical | direct
Continue Reading →
North America

XBiotech Announces First Patient in Phase 2 Study Evaluating MABp1 in Patients with Atopic Dermatitis

First Patient Begins Therapy with MABp1 for Treatment of Atopic Dermatitis XBiotech Inc. (NASDAQ:XBIT) announced today that the first patient has been enrolled in it...
23 May 2018 North America MABp1 | patient
Continue Reading →
Europe

Patient Registries to Bolster Cell- and Gene-Therapy Clinical Trial Data

As the first personalized cell and gene therapies are approved from small clinical trials, researchers propose the creation of publicly accessible databases to pull ...
16 May 2018 Europe bolster | cell
Continue Reading →
Europe

Somerset Partnership Seeks to Increase Patient Participation in Clinical Trials with TriNetX

Somerset Partnership NHS Foundation Trust, which serves a patient population of 650,000 in the south west region of the U.K., is the first integrated mental and com...
25 April 2018 Europe clinical | participation
Continue Reading →
Europe

Polyphor announces enrollment of first patient in Phase III clinical trial for murepavadin – a pathogen-specific antibiotic being developed for the treatment of nosocomial pneumonia

Potentially first new class of antibiotics in Phase III development against Gramnegative pathogens in 50 years Polyphor today announced the enrollment of the first pa...
28 March 2018 Europe clinical | patient
Continue Reading →
news

Acea Health announces funding from Catapult Ventures and PUBLIC to launch innovative digital dental and medical consent platform – Flynotes

Acea Health, a digital healthcare company, today announced the completion of a seed funding round to launch Flynotes – its new digital consent platform. The funding c...
24 January 2018 news consent | dental
Continue Reading →
news

Patient Centricity Becomes a Reality with SQN Health

In drug development, patient participation is crucial to the success of clinical trials. The industry recognises the demand for better in-trial patient data and impro...
10 January 2018 news centricity | clinical data
Continue Reading →
Catalyst: 12th January 2026
Quotient

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte